Physician profile
George Patrick Maxwell
NPI 1295737930
$48,278,000.58
in general payments reported to CMS, 2019-2025
8 companies · $7.2M in 2025
The $7.2M reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $340 · 2021: $208 · 2022: $22M · 2023: $12M · 2024: $7.2M · 2025: $7.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $26M · Food and Beverage: $1,175 · Travel and Lodging: $809 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,011,211.35 |
| Food and Beverage | $1,174.51 |
| Travel and Lodging | $808.87 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $48,249,502.45 | 2022-2025 | |
| Mentor Worldwide LLC | $14,773.17 | 2020-2022 | |
| Kci USA, INC. | $11,306.16 | 2019 | |
| Motiva USA, LLC | $1,564.28 | 2025 | |
| Allergan, INC. | $585.55 | 2019-2022 | |
| Galderma Laboratories, L.P. | $150.00 | 2021 | |
| Sientra, INC. | $95.40 | 2020 | |
| Integra Lifesciences Corporation | $23.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.